iPS cell is an abbreviation of induced pluripotent stem cell, which is an acronym for its English name. Professor Shinya Yamanaka of Kyoto University, who developed this product, was awarded the Nobel Prize in Physiology or Medicine in 2012 based on his results.
High hurdles for safety checks
Establishment of technology to stably
produce high quality cells
Development of manufacturing facilities
We promotes the idea that individuals, research institutions, health care and commercial industries have by building an integrated platform and generates inexpensive medical iPS cells and accelerates the realization of transplantation medicine for various diseases and other services such as insurance.